Tag:
Neuraltus Pharmaceuticals
Latest Headlines
Latest Headlines
A DIY clinical study? Desperate patients try a therapeutic 'home brew'
In this case the object of their desperation is NP001, an experimental drug now in a Phase II study.
Biotech startup touts biomarker effect in PhI ALS study
A small Palo Alto, CA-based biotech has garnered some fresh attention for itself after touting the results of a small Phase I study designed to test its lead drug by measuring its impact on a key...
Neuraltus Pharma raises $17M in first round
Neuraltus Pharmaceuticals, a biotech developing small molecule drugs for neurodegenerative diseases, has wrapped a $17 million Series A round. Co-investing in the Series A funding are Latterell
